跳至主要内容
临床试验/CTRI/2018/06/014450
CTRI/2018/06/014450尚未招募2 期

A prospective open labelled phase II Non randomized clinical trial on herbal formulation of NANNARI VER OORAL KUDINEER for the treatment of VALI AZHAL KEEL VAYU(Rheumatoid arthritis)

Principal1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2018年6月13日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
Principal
入组人数
40
试验地点
1
主要终点
Therapeutic efficacy of trial drug nannari ver ooral kudineer in vali azhal keel vayu

研究概览

简要总结

The study is A Prospective Open Labelled Phase II Non Randomized  clinical study to evaluate the therapeutic  efficacy of NANNARI VER OORAL KUDINEER 90ml TDS for 30 days in 40 patients during the trial period of 14 month that will be contacted in Goverment Siddha Medical College and hospital Palayamkottai Tirunelveli Tamilnadu The Primary outcome will be the therapeutic efficacy of trail drug NANNARI VER OORAL KUDINEER in VALI AZHAL KEEL VAYU The secondary outcome will be the evaluation of Sidha diagnostice parameters safety of trail drug Pharmacolocical and Biochemical analysis of trail drug

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • Symmetrical joint involvement Arthritis of 3 or more joints Florid morning stiffness and swelling that lasts for few hours or days Pain joints swelling especially in the interphalangeal joints Pain criteria score should be greater than or equal to 6.

排除标准

  • Age below 18 and above 50 years Gouty arthritis Psoriatic arthritis Mixed connective tissue disorders SLE Extra pulmonary tuberculosis Other auto immune disease Chronic kidney disease Pregnant women and lactating mothers.

结局指标

主要结局

Therapeutic efficacy of trial drug nannari ver ooral kudineer in vali azhal keel vayu

时间窗: 30 days

次要结局

  • Evaluation of siddha diagnostic parameters safety of trial drug pharmacological and Biochemical analysis of trial drug(30 days)

研究者

发起方
Principal
申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验